Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-action Pt(IV) anticancer agents; do we understand how they work?
Dan Gibson
Journal of Inorganic Biochemistry (2018) Vol. 191, pp. 77-84
Closed Access | Times Cited: 146

Showing 26-50 of 146 citing articles:

An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies
Carlo Marotta, Ester Giorgi, Francesca Binacchi, et al.
Inorganica Chimica Acta (2023) Vol. 548, pp. 121388-121388
Open Access | Times Cited: 19
Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds
Gonzalo Scalese, María Florencia Mosquillo, Leticia Pérez‐Díaz, et al.
Coordination Chemistry Reviews (2024) Vol. 503, pp. 215608-215608
Closed Access | Times Cited: 8
Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6218-6237
Closed Access | Times Cited: 8
Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?
Alvaro Lopez-Sanchez, Hélène Bertrand
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 6, pp. 1639-1667
Closed Access | Times Cited: 7
Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium(IV) complexes with bioactive ligands
Gonzalo Scalese, Ignacio Machado, Fabiana Salazar, et al.
Frontiers in Chemical Biology (2024) Vol. 2
Open Access | Times Cited: 6
Current Status of Novel Multifunctional Targeted Pt(IV) Compounds and Their Reductive Release Properties
Ling‐Wen Xu, Xiangyu Kong, Xinzhi Li, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 746-746
Open Access | Times Cited: 6
Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance
Xiaochao Huang, Guimei Li, Huifang Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8020-8042
Closed Access | Times Cited: 6
A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton
Hana Kostrhunová, Juraj Zajac, Vojtěch Novohradský, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 10, pp. 5176-5190
Closed Access | Times Cited: 54
Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules
Tomer Babu, Amrita Sarkar, Subhendu Karmakar, et al.
Inorganic Chemistry (2020) Vol. 59, Iss. 7, pp. 5182-5193
Closed Access | Times Cited: 49
Anticancer Potential of Diiron Vinyliminium Complexes
Dalila Rocco, Lucinda K. Batchelor, Gabriele Agonigi, et al.
Chemistry - A European Journal (2019) Vol. 25, Iss. 65, pp. 14801-14816
Open Access | Times Cited: 43
Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents
Rui‐Rong Ye, Cai‐Ping Tan, Bi-Chun Chen, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 40
Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel
Baohua Wang, Wenxia Hu, Hongjiang Yan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111249-111249
Open Access | Times Cited: 38
Cancer molecular biology and strategies for the design of cytotoxic gold(i) and gold(iii) complexes: a tutorial review
Danielle Westhuizen, Daniela I. Bezuidenhout, Orde Q. Munro
Dalton Transactions (2021) Vol. 50, Iss. 47, pp. 17413-17437
Open Access | Times Cited: 34
Multifunctional organometallic compounds for the treatment of Chagas disease: Re(i) tricarbonyl compounds with two different bioactive ligands
Mariano Soba, Gonzalo Scalese, Federico Casuriaga, et al.
Dalton Transactions (2023) Vol. 52, Iss. 6, pp. 1623-1641
Closed Access | Times Cited: 15
Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors
Teona Paresishvili, Zurab Kakabadze
Oncology Reviews (2023) Vol. 17
Open Access | Times Cited: 14
Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells
Juraj Zajac, Vojtěch Novohradský, Lenka Marková, et al.
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 8, pp. 3329-3335
Closed Access | Times Cited: 41
Rethinking Alkylating(-Like) Agents for Solid Tumor Management
Hélène Lajous, Bénédicte Lelièvre, Élodie Vauléon, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 5, pp. 342-357
Open Access | Times Cited: 39
A Multi‐action PtIV Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells
Hana Kostrhunová, Juraj Zajac, Lenka Marková, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 47, pp. 21157-21162
Closed Access | Times Cited: 39
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen †
Mauro Ravera, Ilaria Zanellato, Elisabetta Gabano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3074-3074
Open Access | Times Cited: 37
Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells
Subhendu Karmakar, Hana Kostrhunová, Tereza Ctvrtlikova, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13861-13877
Closed Access | Times Cited: 36
Axial functionalisation of photoactive diazido platinum(iv) anticancer complexes
Huayun Shi, Cinzia Imberti, Guy J. Clarkson, et al.
Inorganic Chemistry Frontiers (2020) Vol. 7, Iss. 19, pp. 3533-3540
Open Access | Times Cited: 34
Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy
Dileep Kumar, Dipanjan Karati, Kakasaheb Mahadik, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 8, pp. 1478-1495
Closed Access | Times Cited: 28
A single microbubble formulation carrying 5-fluorouridine, Irinotecan and oxaliplatin to enable FOLFIRINOX treatment of pancreatic and colon cancer using ultrasound targeted microbubble destruction
Jinhui Gao, Keiran Logan, Heather Nesbitt, et al.
Journal of Controlled Release (2021) Vol. 338, pp. 358-366
Open Access | Times Cited: 27
Advances in metal-based nano drugs and diagnostic probes for tumor
Jiayue Ding, Zhijing He, Yujia Zhai, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215594-215594
Closed Access | Times Cited: 11
Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance
Meng Wang, Guimei Li, Nan Xu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Scroll to top